| 1 day | +0.50% |
| |||
| 1 week | +1.88% |
| |||
| 4 week |
| -2.61% | |||
| 3 month | +4.40% |
| |||
| YTD | +7.88% |
| |||
| 1 year | +28.16% |
| |||
| 3 years* | +10.54% |
| |||
| 5 years* |
| -0.49% | |||
| *annualized | |||||
| Best 3 month return | +31.66% | |
| Worst 3 month return | -35.15% |
| Return | Risk | Rating | |
| 3 years | Above Average | Below Average |
|
| 5 years | Average | Below Average |
|
| 10 years | Average | Below Average |
|
| Overall | Average | Below Average |
|
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
| Total assets | 3.34B | |
| Front load | - | |
| Deferred load | - | |
| Expense ratio | 0.44% | |
| Management fee | - | |
| Fund family | GMO |
| Cash | 2.59% | |
| Stocks | 97.53% | |
| Bonds | 0.00% | |
| Other | -0.12% |
| Initial | $300,000,000 |
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | -4.05 | 1.15 | -0.20 | -0.04 | |
| Beta* | 1.12 | 0.97 | 0.98 | 0.98 | |
| Mean annual return | 2.28 | 1.08 | 0.08 | 0.79 | |
| R-squared* | 92.65 | 97.36 | 97.87 | 97.38 | |
| Standard deviation | 10.80 | 17.94 | 23.06 | 18.08 | |
| Sharpe ratio | 2.53 | 0.72 | 0.03 | 0.43 | |
| * Against standard index | |||||
| Security | Net Assets | |
| Total SA (FP) | 3.77% | |
| Sanofi (SAN) | 2.84% | |
| Future Contract On S&P/Tsx 60 Ix Fut Mar13 /Cad/ | 2.50% | |
| AstraZeneca PLC (AZN) | 2.32% | |
| BP PLC (BPAQF) | 2.31% | |
| Banco Santander SA (BCDRF) | 2.00% | |
| GMO US Treasury | 1.90% | |
| Future Contract On Ftse/Mib Idx Fut Mar13 /Eur/ | 1.89% | |
| Rio Tinto PLC (RTPPF) | 1.76% | |
| E. On SE (ENAKF) | 1.60% |